<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref103">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Moss</surname>
    <given-names>R. B.</given-names>
   </name>
   <name>
    <surname>Hansen</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Sanders</surname>
    <given-names>R. L.</given-names>
   </name>
   <name>
    <surname>Hawley</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Steigbigel</surname>
    <given-names>R. T.</given-names>
   </name>
  </person-group> (
  <year>2012</year>). 
  <article-title>A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection</article-title>. 
  <source>J. Infect. Dis.</source>
  <volume>206</volume>, 
  <fpage>1844</fpage>â€“
  <lpage>1851</lpage>. 
  <pub-id pub-id-type="doi">10.1093/infdis/jis622</pub-id>, PMID: 
  <?supplied-pmid 23045618?>
  <pub-id pub-id-type="pmid">23045618</pub-id>
 </mixed-citation>
</ref>
